Researchers from the p53 Laboratory of Singapore's Agency for Science, Technology and Research (A*STAR), have made a finding that makes feasible a unique method of cancer treatment. Their work, published online in the leading journal Cell Death and Differentiation today , offers new insight on how to tap on the properties of p53, the 'guardian of the genome' , to more effectively kill cancer cells while sparing normal cells. The researchers, led by Dr Cheok Chit Fang and Prof David Lane, the co-discoverer of the p53 gene in 1979, achieved this by exploiting one of the key functions of p53 - the control of the cell cycle. Full StoryRelated:
Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments - EurekAert
Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments - Bioscience Technology Online
Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments - e! Science News
